Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 01/20/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications

Immunoadsorption and plasmapheresis at the ICU - A description of the frequencies and indications in a single center experience and a case report.

Condition: Granulomatosis with Polyangiitis
Journal: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Treatment Used: Immunoadsorption
Number of Patients: 72
Published: December 05, 2022

Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis.

Condition: Granulomatosis with Polyangiitis (GPA)
Journal: JAMA network open
Treatment Used: Rituximab vs. Cyclophosphamide Induction Therapy
Number of Patients: 194
Published: November 28, 2022

Benralizumab in the management of rare primary eosinophilic lung diseases.

Condition: Primary Eosinophilic Lung Diseases
Journal: Allergy and asthma proceedings
Treatment Used: Benralizumab
Number of Patients: 0
Published: November 06, 2022

Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT.

Condition: Anti-Neutrophil Cytoplasm Antibody-Associated Vasculitis
Journal: Health technology assessment (Winchester, England)
Treatment Used: Plasma Exchange and Glucocorticoids
Number of Patients: 704
Published: September 26, 2022

Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience.

Condition: Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Journal: International archives of allergy and immunology
Treatment Used: Mepolizumab
Number of Patients: 25
Published: September 20, 2022

How best to manage relapse and remission in ANCA-associated vasculitis.

Condition: Relapse and Remission in ANCA-Associated Vasculitis (AAV)
Journal: Expert review of clinical immunology
Treatment Used: Glucocorticoids (GCs) Combined with Cyclophosphamide (CYC) or Rituximab (RTX)
Number of Patients: 0
Published: September 14, 2022

Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Condition: Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
Journal: JAMA network open
Treatment Used: Rituximab
Number of Patients: 93
Published: July 08, 2022

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study.

Condition: Eosinophilic Granulomatosis with Polyangiitis (EGPA)
Journal: Arthritis research & therapy
Treatment Used: Mepolizumab (MPZ)
Number of Patients: 20
Published: June 29, 2022

SUCCESSFUL TREATMENT FOR OTITIS MEDIA AND SINUSITIS ASSOCIATED WITH EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS USING ANTI-IL-5 RECEPTOR MONOCLONAL ANTIBODY BENRALIZUMAB.

Condition: Eosinophilic Granulomatosis with Polyangiitis (EGPA) with Sinusitis and Otitis Media
Journal: Arerugi = [Allergy]
Treatment Used: Benralizumab
Number of Patients: 1
Published: May 15, 2022

The use of ECMO in pediatric granulomatosis with polyangiitis.

Condition: Granulomatosis with Polyangiitis
Journal: Pediatric rheumatology online journal
Treatment Used: ECMO
Number of Patients: 1
Published: May 10, 2022

Rituximab treatment in ANCA-associated vasculitis patients: outcomes of a real-life experience from an observational cohort.

Condition: ANCA-Associated Vasculitis
Journal: Clinical rheumatology
Treatment Used: Rituximab
Number of Patients: 42
Published: May 04, 2022

Therapeutic advances in eosinophilic granulomatosis with polyangiitis.

Condition: Eosinophilic Granulomatosis with Polyangiitis
Journal: Current opinion in rheumatology
Treatment Used: Anti-IL-5 Agents, Rituximab
Published: April 20, 2022
Showing 1-12 of 128

Last Updated: 01/20/2023